PL364747A1 - Użycie przeciwciał w szczepionkach przeciwko nowotworom - Google Patents

Użycie przeciwciał w szczepionkach przeciwko nowotworom

Info

Publication number
PL364747A1
PL364747A1 PL00364747A PL36474700A PL364747A1 PL 364747 A1 PL364747 A1 PL 364747A1 PL 00364747 A PL00364747 A PL 00364747A PL 36474700 A PL36474700 A PL 36474700A PL 364747 A1 PL364747 A1 PL 364747A1
Authority
PL
Poland
Prior art keywords
antibodies
anticancer vaccination
vaccination
anticancer
prophylactically
Prior art date
Application number
PL00364747A
Other languages
English (en)
Other versions
PL201533B1 (pl
Inventor
Helmut Eckert
Hans Loibner
Original Assignee
Igeneon Krebs-Immuntherapie Forschungs- Und Entwicklungs-Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs-Immuntherapie Forschungs- Und Entwicklungs-Ag filed Critical Igeneon Krebs-Immuntherapie Forschungs- Und Entwicklungs-Ag
Publication of PL364747A1 publication Critical patent/PL364747A1/pl
Publication of PL201533B1 publication Critical patent/PL201533B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL364747A 1999-01-13 2000-01-12 Zastosowanie przeciwciała skierowanego przeciwko antygenowi błony komórkowej Ep-CAM PL201533B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5199 1999-01-13

Publications (2)

Publication Number Publication Date
PL364747A1 true PL364747A1 (pl) 2004-12-13
PL201533B1 PL201533B1 (pl) 2009-04-30

Family

ID=4178206

Family Applications (1)

Application Number Title Priority Date Filing Date
PL364747A PL201533B1 (pl) 1999-01-13 2000-01-12 Zastosowanie przeciwciała skierowanego przeciwko antygenowi błony komórkowej Ep-CAM

Country Status (28)

Country Link
US (3) US7691372B2 (pl)
EP (2) EP1230932B1 (pl)
JP (1) JP4774551B2 (pl)
KR (1) KR100771752B1 (pl)
CN (1) CN1188169C (pl)
AT (2) ATE219687T1 (pl)
AU (1) AU768515B2 (pl)
CA (1) CA2360382C (pl)
CZ (1) CZ302801B6 (pl)
DE (2) DE50009240D1 (pl)
DK (2) DK1230932T3 (pl)
EE (1) EE05474B1 (pl)
ES (2) ES2177509T3 (pl)
HK (1) HK1044487B (pl)
HR (1) HRP20010526A2 (pl)
HU (1) HU226150B1 (pl)
ID (1) ID30223A (pl)
IL (2) IL144265A0 (pl)
IS (1) IS5998A (pl)
MX (1) MXPA01007148A (pl)
NO (1) NO329917B1 (pl)
NZ (1) NZ512722A (pl)
PL (1) PL201533B1 (pl)
PT (2) PT1230932E (pl)
SI (2) SI1230932T1 (pl)
SK (1) SK286627B6 (pl)
TR (1) TR200102034T2 (pl)
WO (1) WO2000041722A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL201533B1 (pl) * 1999-01-13 2009-04-30 Igeneon Krebs Immuntherapie Zastosowanie przeciwciała skierowanego przeciwko antygenowi błony komórkowej Ep-CAM
AT410172B (de) 2000-03-21 2003-02-25 Igeneon Gmbh Verfahren zur herstellung einer vakzineformulierung
AT502293B1 (de) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie Immunogener, monoklonaler antikörper
AT500647A1 (de) * 2002-05-21 2006-02-15 Igeneon Krebs Immuntherapie Verwendung eines impfstoffes
AT500650B1 (de) * 2003-04-17 2009-11-15 Altropus Gmbh Immunogener rekombinanter antikörper
AT500651B9 (de) * 2003-05-27 2010-04-15 Altropus Gmbh Aktiv immunisierender antikörper
WO2006005367A1 (en) 2004-07-14 2006-01-19 Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag N-glycosylated antibody
EP1618890B1 (en) * 2004-07-20 2010-10-06 Altropus Gmbh Use of antibodies in a very low dose for the vaccination against cancer
EP1874342B1 (en) * 2005-04-26 2018-06-06 Eisai R&D Management Co., Ltd. Compositions and methods for cancer immunotherapy
WO2007008943A2 (en) 2005-07-08 2007-01-18 Xencor, Inc. Optimized anti-ep-cam antibodies
EP1762575A1 (en) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification of tumor-associated antigens for diagnosis and therapy
AT504231A1 (de) 2006-10-03 2008-04-15 Hans Dr Loibner Prädiktive parameter
EP2356992B1 (en) 2007-12-07 2017-08-16 N.V. Nutricia Bifidobactrium for dust mite allergy
EP3181583A1 (en) 2009-02-24 2017-06-21 ESBATech, an Alcon Biomedical Research Unit LLC Methods for identifying immunobinders of antigens
US8887373B2 (en) 2012-02-24 2014-11-18 Covidien Lp Vessel sealing instrument with reduced thermal spread and method of manufacture therefor
US20140276968A1 (en) * 2013-03-14 2014-09-18 Ethicon, Inc. Applicator systems for surgical fasteners
WO2015013668A1 (en) * 2013-07-26 2015-01-29 Ke Zhang Anti-immunoglobulin e antibodies and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
US5270202A (en) 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5798100A (en) * 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
WO1997005597A1 (en) * 1995-07-31 1997-02-13 Litton Systems Canada Limited Flat panel pixel array incorporating photoconductive switches
WO1997015597A1 (en) * 1995-10-25 1997-05-01 Centocor B.V. HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE
US6235280B1 (en) 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
IL121041A0 (en) * 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
US6274143B1 (en) * 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
US6881405B2 (en) * 1998-06-15 2005-04-19 Altarex Medical Corp. Reagents and methods for inducing an immune response to prostate specific antigen
PL201533B1 (pl) * 1999-01-13 2009-04-30 Igeneon Krebs Immuntherapie Zastosowanie przeciwciała skierowanego przeciwko antygenowi błony komórkowej Ep-CAM
AU2001261371A1 (en) 2000-05-16 2001-11-26 New York University Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same

Also Published As

Publication number Publication date
EP1230932A2 (de) 2002-08-14
TR200102034T2 (tr) 2001-11-21
ATE219687T1 (de) 2002-07-15
KR100771752B1 (ko) 2007-10-30
JP4774551B2 (ja) 2011-09-14
DK1140168T3 (da) 2002-09-30
JP2002534481A (ja) 2002-10-15
CA2360382C (en) 2011-05-24
SI1230932T1 (en) 2005-06-30
MXPA01007148A (es) 2002-03-27
ES2177509T3 (es) 2002-12-16
HUP0200527A2 (en) 2002-06-29
US7691372B2 (en) 2010-04-06
EP1140168B1 (de) 2002-06-26
DK1230932T3 (da) 2005-04-25
ID30223A (id) 2001-11-15
US20120003232A1 (en) 2012-01-05
EE05474B1 (et) 2011-10-17
DE50009240D1 (de) 2005-02-17
NO20013093D0 (no) 2001-06-21
CN1344167A (zh) 2002-04-10
NO329917B1 (no) 2011-01-24
EE200100366A (et) 2002-10-15
NO20013093L (no) 2001-09-10
PL201533B1 (pl) 2009-04-30
AU2796400A (en) 2000-08-01
EP1230932A3 (de) 2003-11-26
IS5998A (is) 2001-07-10
SK9642001A3 (en) 2002-03-05
IL144265A (en) 2006-08-20
US20070224202A1 (en) 2007-09-27
WO2000041722A1 (de) 2000-07-20
DE50000243D1 (de) 2002-08-01
CA2360382A1 (en) 2000-07-20
SI1140168T1 (en) 2002-10-31
PT1230932E (pt) 2005-04-29
CZ302801B6 (cs) 2011-11-16
EP1140168A1 (de) 2001-10-10
CN1188169C (zh) 2005-02-09
IL144265A0 (en) 2002-05-23
HK1044487B (zh) 2005-09-16
ATE286745T1 (de) 2005-01-15
ES2236375T3 (es) 2005-07-16
SK286627B6 (sk) 2009-02-05
US20100233178A1 (en) 2010-09-16
HK1044487A1 (en) 2002-10-25
HU226150B1 (en) 2008-05-28
PT1140168E (pt) 2002-11-29
KR20010101446A (ko) 2001-11-14
US8444974B2 (en) 2013-05-21
AU768515B2 (en) 2003-12-18
NZ512722A (en) 2003-07-25
CZ20012581A3 (cs) 2002-01-16
HRP20010526A2 (en) 2002-08-31
EP1230932B1 (de) 2005-01-12

Similar Documents

Publication Publication Date Title
PL364747A1 (pl) Użycie przeciwciał w szczepionkach przeciwko nowotworom
TR200001253T2 (tr) Tümöre özel antijenler
DE60134962D1 (de) Anti-ccr4 antikörper und fragmente davon
NZ527283A (en) Modified antibodies and methods of use
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
SI1734995T1 (sl) Monoklonska protitelesa proti hepatocitnemu rastnemu faktorju
NZ514228A (en) Method of Expressing Antigens on the Surface of Antigen Presenting Cells by Photochemical Internalisation
AU2002352394A1 (en) Focussed antibody technology
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
CY1106400T1 (el) Συνθεση και μεθοδος ανοσοθepαπειας με καρκινικο αντιγονο
MD1374G2 (ro) Anticorpi monoclonali imunostimulatori, procedeu de obţinere a acestora, linii celulare, metodă de tratare a maladiilor şi compoziţie farmaceutică
WO2000020041A8 (en) Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
WO2004106379A8 (en) Immunotherapy of rectal cancer
SE9903534D0 (sv) Vaccin
IL160029A0 (en) Receptor, the use thereof, and mouse antibodies
WO2002038611A3 (en) Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins
MXPA04000652A (es) Identificacion de antigenos especificos del tumor por medio de seleccion de bibliotecas de acido desoxirribonucleico complementario con sueros y uso de antigenos en tratamiento de tumores.
AU2002326318A1 (en) Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer
BR0007814A (pt) Uso de anticorpos para a vacinação contra câncer
MY143402A (en) Preparations used in the treatment and prophilaxis of mycobacterial infections
ZA200200730B (en) Human monoclonal antibodies to prostate specific membrane antigen.
AU2002307822A1 (en) Generation of monoclonal antibodies to poorly immunogenic antigens expressed or carried by eukaryotic cells, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130112